Argentina is one of the first countries in the Region of the Americas to provide the WHO-recommended human papillomavirus (HPV) vaccine to girls to prevent cervical cancer later in life. The Pan American Health Organization (PAHO), WHO’s Regional Office for the Americas, runs a Revolving Fund for the procurement of vaccines, syringes and related supplies for participating Member States. It ensures that immunization programmes have a continuous supply of high-quality products for a low price. Argentina acquires the HPV vaccines through the PAHO Revolving Fund.
